Aspira Women’s Health Wins Laboratory Service Contract with University of Texas Medical Branch at Galveston

Aspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women’s Health Inc., abio-analytical-based women’s health company focused on gynecologic disease diagnostics, today announced it has executed a new laboratory services agreement with University of Texas Medical Branch…

Read More

OTC Markets Group Welcomes Aspira Women’s Health Inc. to OTCQX

NEW YORK, Oct. 14, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Aspira Women’s Health Inc. (OTCQX: AWHL), an AI enhanced bio-analytical based women’s health company, has qualified to trade on the OTCQX® Best Market. Aspira Women’s Health Inc. upgraded to OTCQX from the…

Read More